<DOC>
	<DOCNO>NCT00236288</DOCNO>
	<brief_summary>To test feasibility intensive behavioral pharmacologic tobacco cessation program radiation oncology patient families/companions .</brief_summary>
	<brief_title>A Feasibility Study Smoking Cessation Program Radiation Oncology</brief_title>
	<detailed_description>There overwhelm evidence support tobacco use number one cause preventable cancer cardiovascular death . Smoking responsible least 30 % cancer death nearly 90 % lung cancer death . There robust phase III randomize data show improve smoking cessation behavioral strategy well pharmacologic intervention bupropion . Despite significant evidence show survival , toxicity quality life detriment cancer patient continue smoke diagnosis , roughly one third cancer patient continue use tobacco . There relative paucity data regard smoke cessation program cancer patient population . Several single institution , well cooperative group ( ECOG ) , effort publish vary result . However , date , publish report success pharmacologic smoke cessation intervention cancer patient . Patients undergo definitive/curative radiotherapy often receive daily treatment course three eight week . They often accompany supported daily family member companion , many smoke . This represent huge exposure health care system unique opportunity intensive intervention cancer patient families/companions `` daily routine '' radiotherapy . To date , publish report intensive tobacco cessation intervention concurrent radiotherapy cancer patient family companion . We propose feasibility study intensive tobacco cessation program deliver radiation oncology patient and/or family/companions concurrent plan radiotherapy . This program feature intensive behavioral intervention well pharmacologic agent bupropion .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Eligibility Radiotherapy Patients age 18 year old receive three week external beam radiotherapy report smoke one cigarettes past 30 day selfidentify smoker Cancer Stage : Stage IIII IVa Head Neck Malignancy allow Stage IIV breast , prostate , testis lymphoma also allow least one year life expectancy give write informed consent KPS 70100 Eligibility Family/Companions Radiotherapy Patients ( Note : Family members/companions eligible protocol regardless whether index radiotherapy patient eligible willing participate . ) age 18 year old least one year life expectancy radiotherapy patient receive three week external beam radiotherapy Person commit bringing/accompanying patient radiotherapy least three day per week . report smoke one cigarettes past 30 day selfidentify smoker Family member/companion patient radiotherapy treatment stage cancer give write informed consent KPS 70100 Exclusion Criteria Radiotherapy Patients Families/Companions serious unstable cardiac , renal , hypertensive , pulmonary , endocrine , neurologic disorder , assess studysite physician current diagnosis major depressive episode history panic disorder , psychosis , bipolar disorder , eat disorder pregnancy lactation history allergy/intolerance adverse reaction bupropion history seizure disorder , bulimia anorexia nervosa use MAOi within 14 day current use another antidepressant abrupt discontinuation alcohol sedatives unwilling/unable meet behavioral interventionalist 20 minute , least 3 day per week course radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Cancer treatment tobacco abuse</keyword>
</DOC>